Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about ...

Find out how ADT + ARPI outperforms ADT alone in mHSPC, boosting survival and treatment persistence. Read more on real-world ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says prostate cancer is the second-most common cause of cancer death in men, accounting ...

Dr. Matthew Smith answers the question: 'Hormone Refractory Prostate Cancer?' March 16, 2009 -- Question: What is hormone refractory prostate cancer? Answer: Nearly all men respond to initial ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

“Prostate cancer is a malignancy that commences in the prostate ... His PSA levels have recently begun to rise, and he faces ...

WASHINGTON — Former President Joe Biden is receiving radiation and hormone therapy as part of a new phase of treating the aggressive form of prostate cancer he was diagnosed with after leaving office, ...